CM
CERE

Crystalline Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Crystalline Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,918
Closed -$365K – 112
2024
Q2 		$365K Buy
+8,918
New +$365K 0.35% 37